Louis, and serves as Medical Director for Clinical Research in the Division of Oncology. His research is focused on the development of new agents and treatment approaches for patients with myelodysplastic syndromes and acute leukemias. Specifically, his group is interested in modulating tumor microenvironment interactions as a therapeutic approach for acute leukemias and in the use of next generation sequencing technologies to measure disease response in myelodysplastic syndromes and acute myeloid leukemia.